AI, Microbiomes, & 8 Orders of Magnitude Improvement
Summary – I recently sat down with Pascal Côté on the WATSNEX Podcast to discuss “AI, Microbiomes, and 8 Orders of Magnitude Improvement.” We dove deep into how industrial-scale microbiome mining and data depth are transforming biotech manufacturing and drug discovery. This conversation is part of the WATSNEX Podcast Founding Series, featuring leaders in biopharma and medtech. Watch the full episode here: https://youtu.be/16dg9QKOEcM
Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo (Jan 27, 2026) by Reuters. BERLIN, Jan 27 (Reuters) – Roche’s experimental obesity drug, which works in a similar way to Eli Lilly’s Zepbound, produced as much as 22.5% weight loss in a mid-stage trial, underpinning the Swiss drugmaker’s efforts to catch up with
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position (March 30, 2026) by Angus Liu Disclosed in January 2026, Roche paid $100 million for a nonexclusive license to patents from Structure Therapeutics. This strategic move protects Roche’s oral GLP-1 candidate, CT-996, from potential patent litigation. Read More
